Cargando…
Efficacy of an anti-cancer strategy targeting SET in canine osteosarcoma
Osteosarcoma (OSA) is the most common bone tumor in dogs. Protein phosphatase 2A (PP2A), an evolutionary conserved serine/threonine protein phosphatase, is a crucial tumor suppressor. SET is a PP2A inhibitory protein that directly interacts with PP2A and suppresses its phosphatase activity. SET has...
Autores principales: | TSUJI, Shunya, OHAMA, Takashi, NAKAGAWA, Takayuki, SATO, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Veterinary Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863715/ https://www.ncbi.nlm.nih.gov/pubmed/31527340 http://dx.doi.org/10.1292/jvms.19-0311 |
Ejemplares similares
-
Anti-tumor effects of perphenazine on canine lymphoma
por: TSUJI, Shunya, et al.
Publicado: (2016) -
The therapeutic effects of SET/I2PP2A inhibitors on canine
melanoma
por: ENJOJI, Shuhei, et al.
Publicado: (2015) -
The role of SET/I2PP2A in canine mammary tumors
por: Kake, Satoru, et al.
Publicado: (2017) -
Characterization of SET/I2PP2A Isoforms in Dogs
por: YABE, Ryotaro, et al.
Publicado: (2014) -
Distribution of SET/I2PP2A protein in gastrointestinal tissues
por: Umata, Koji, et al.
Publicado: (2019)